Cart
sales@molnova.com
Adenine hydrochloride
CAS No. 2922-28-3
Adenine hydrochloride( Adenine hydrochloride | Leucon )
Catalog No. M18378 CAS No. 2922-28-3
Adenine HCl is a hydrochloride salt form of adenine which is a nucleobase with a variety of roles in biochemistry.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 28 | In Stock |
|
Biological Information
-
Product NameAdenine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdenine HCl is a hydrochloride salt form of adenine which is a nucleobase with a variety of roles in biochemistry.
-
DescriptionAdenine hydrochloride.
-
In Vitro——
-
In Vivo——
-
SynonymsAdenine hydrochloride | Leucon
-
PathwayOthers
-
TargetOther Targets
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2922-28-3
-
Formula Weight171.59
-
Molecular FormulaC5H5N5·HCl
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (291.39 mM)
-
SMILESc1nc2c([nH]1)c(ncn2)N.Cl
-
Chemical Name1H-Purin-6-amine, monohydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Silwal P, et al. Mol Immunol. 2015 Jun;65(2):242-9.
molnova catalog
related products
-
Corysamine chloride
Corysamine chloride was identified to inhibit the activity of ACHE.
-
Methyl 2-hydroxy-3,4...
From Eriostemon crowei.
-
Pseudo RACK1
Activator of protein kinase C; attached to cell permeabilization Antennapedia domain vector peptide. Consists of peptide derived from the C2 domain of PKC β linked by a disulfide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the activator peptide. Once inside the cell, the disulfide bonds are subjected to reduction in the cytoplasm leading to release of the activator peptide.
